Supposed pituitary-production of human chorionic Gonadotropin induced by androgen deprivation therapy

Supposed pituitary-production of human chorionic Gonadotropin induced by androgen deprivation therapy

ABSTRACT Introduction: The main cause of slightly elevated human chorionic gonadotropin (HCG) after successful treatment of male germ cell tumors is considered to be pituitary-derived HCG. It is well known that pituitary-derived HCG is frequently detected in postmenopausal women. We evaluated the s...

Full description

Bibliographic Details
Main Authors:	Koji Yoshimura, Yoshiharu Nakashima, Kyohei Sugiyama, Naoki Kohei, Akitoshi Takizawa
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Urologia
Series:	International Brazilian Journal of Urology
Subjects:	Chorionic Gonadotropin Neoplasms, Germ Cell and Embryonal Androgens Luteinizing Hormone
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382019000100038&lng=en&tlng=en

Similar Items

Endometrial carcinoma with ectopic human chorionic gonadotropin expression
by: Regina Lee, et al.
Published: (2015-04-01)

Pregnancy Rate by Human Chorionic Gonadotropin Administration Versus Urinary Luteinizing Hormone Surge Method in Patients Undergoing Intrauterine Insemination
by: Seyedeh Houra Vahedolain, et al.
Published: (2016-10-01)

Endocrine dysfunction in Taiwanese children with human chorionic gonadotropin-secreting germ cell tumors
by: Chien-Ming Lin, et al.
Published: (2014-02-01)

Effect of exogenous human chorionic gonadotropin on ovulation in mice
by: S. Ya. Amstislavsky, et al.
Published: (2020-01-01)

Differential diagnosis of elevated human chorionic gonadotropin in women
by: Anthony Williams
Published: (2023-03-01)

THE ROLE OF HUMAN CHORIONIC GONADOTROPIN IN THE TREATMENT OF RETRACTILE TESTIS
by: Sadik Hasan Kaddim
Published: (2016-12-01)

Unusual false-negative serum human chorionic gonadotropin detected by qualitative immunoassay: a case report of two Iraqi women
by: Falah H.O Al-Khikani, et al.
Published: (2020-01-01)

Unnecessary test ordering in clinical trials: human chorionic gonadotropin as an example
by: Alegre Estibaliz, et al.
Published: (2020-01-01)

Fetal gender, serum human chorionic gonadotropin, and testosterone in women with preeclampsia
by: Zakia M. Ibrahim, et al.
Published: (2020-07-01)

Influence of metformin therapy and treatment with an allosteric luteinizing hormone agonist and chorionic gonadotropin on spermatogenesis in male rats with obesity
by: K. V. Derkach, et al.
Published: (2023-11-01)

Human Chorionic Gonadotropin monotherapy for the treatment of hypogonadal symptoms in men with total testosterone > 300 ng/dL
by: Vinayak Madhusoodanan, et al.
Published: (2019-11-01)

Advanced esophageal carcinoma expressing Human Chorionic Gonadotropin (HCG-b)
by: Kutty Geeta, et al.
Published: (2013-01-01)

Glycan signatures for the identification of cisplatin‐resistant testicular cancer cell lines: Specific glycoprofiling of human chorionic gonadotropin (hCG)
by: Michal Hires, et al.
Published: (2022-02-01)

Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the “Personalized” Medicine Era: A Meta-analysis
by: Daniele Santi, et al.
Published: (2017-06-01)

Comparison of Steroidogenic and Ovulation-Inducing Effects of Orthosteric and Allosteric Agonists of Luteinizing Hormone/Chorionic Gonadotropin Receptor in Immature Female Rats
by: Kira V. Derkach, et al.
Published: (2023-11-01)

Response: Commentary: Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the “Personalized” Medicine Era: A Meta-analysis
by: Daniele Santi, et al.
Published: (2018-03-01)

Comparison of Human Chorionic Gonadotropin Test and Amnisure Test for Diagnosis of Premature Rapture of Membrane
by: Esmat Barooti, et al.
Published: (2019-01-01)

Single‐dose pharmacokinetic study comparing the pharmacokinetics of recombinant human chorionic gonadotropin in healthy Japanese and Caucasian women and recombinant human chorionic gonadotropin and urinary human chorionic gonadotropin in healthy Japanese women
by: Wilhelmina Bagchus, et al.
Published: (2018-01-01)

Success rate of undescended testicle treatment with human chorionic gonadotropin
by: Ležakov Ognjen, et al.
Published: (2019-01-01)

Should human chorionic gonadotropine treatment increase thyroid volume?
by: Ayten Oguz, et al.
Published: (2015-08-01)

Impact of clinical characteristics on human chorionic gonadotropin regression after molar pregnancy
by: Allison A. Gockley, et al.
Published: (2021-08-01)

Case report: Fluctuating tumor markers in a boy with gonadotropin-releasing hormone-independent precocious puberty induced by a pineal germ cell tumor
by: Alessandro Cattoni, et al.
Published: (2022-08-01)

Use of Human Chorionic Gonadotropin and Vaginal Progesterone Suppositories For Luteal Phase Support in Gonadotropin-Induced Cycles: A Comparative Study
by: Emel Ebru Özçimen, et al.
Published: (2006-04-01)

Human Chorionic Gonadotropin Influences Systemic Autoimmune Responses
by: Alpana De, et al.
Published: (2018-12-01)

Evaluation of Endometrial Angiogenesis in Mice Uterus Before Implantation in Natural Cycles Followed by Use of Human Menopausal Gonadotropin - Human Chorionic Gonadotropin Drugs and Epigallocatechin Gallate
by: Bahman Rashidi, et al.
Published: (2017-01-01)

Modulation of Gonadotropins Activity by Antibodies
by: Elodie Kara, et al.
Published: (2019-02-01)

Testicular Torsion: Preliminary Results of In Vitro Cell Stimulation Using Chorionic Gonadotropin
by: Andrea Errico, et al.
Published: (2022-01-01)

Impact of intrauterine administration of human chorionic gonadotropin before intrauterine insemination in infertile women: A randomized controlled trial
by: Leena Wadhwa, et al.
Published: (2021-01-01)

Association of endocrine disrupting chemicals exposure with human chorionic gonadotropin concentrations in pregnancy
by: Arash Derakhshan, et al.
Published: (2023-08-01)

Satisfaction and usability of the recombinant chorionic gonadotropin prefilled pen: a survey in Italy
by: Chiara Dallagiovanna, et al.
Published: (2022-01-01)

The relationship between the variants in the 5′-untranslated regions of equine chorionic gonadotropin genes and serum equine chorionic gonadotropin levels
by: ShuQin Liu, et al.
Published: (2017-12-01)

Human chorionic gonadotropin (hCG)-induced ovulation occurs later but with equal occurrence in lactating dairy cows: comparing hCG and gonadotropin-releasing hormone protocols
by: Tsung-Ching LIU, et al.
Published: (2019-10-01)

Clinical outcomes of assisted reproductive technology treatment by using a self‐injection of recombinant human chorionic gonadotropin as the final maturation trigger
by: Koji Nakagawa, et al.
Published: (2018-04-01)

Salivary human chorionic gonadotropin as a novel biomarker for early detection of pregnancy: A pilot study
by: Madhura Mahajan, et al.
Published: (2019-01-01)

Luteinizing Hormone Receptor Is Expressed in Testicular Germ Cell Tumors: Possible Implications for Tumor Growth and Prognosis
by: Mette Lorenzen, et al.
Published: (2020-05-01)

Immunoassay for Human Chorionic Gonadotropin Based on Glassy Carbon Electrode Modified with an Epitaxial Nanocomposite
by: Akram Valipour, et al.
Published: (2017-06-01)

Rapidly Progressive Precocious Puberty With an Elevated Testosterone Level in a 5-Year-Old Boy With a β-Human Chorionic Gonadotropin-Secreting Intracranial Germ Cell Tumor in the Pineal Gland
by: Maria Graciela Parra Villasmil, MD, et al.
Published: (2022-07-01)

Acquired uterine vascular abnormalities associated with persistent human chorionic gonadotropin: Experience at a Korean teaching hospital
by: Da Hye Ju, et al.
Published: (2015-12-01)

Comparative Pharmacokinetics, Bioequivalence and Safety Study of Two Recombinant Human Chorionic Gonadotropin Injections in Healthy Chinese Subjects
by: Wang J, et al.
Published: (2020-01-01)

Clinical efficacy of dual trigger with human chorionic gonadotropin and a gonadotropin‐releasing hormone agonist for women undergoing fertility preservation
by: Yeon Hee Hong, et al.
Published: (2022-01-01)